Following the news that Chinese regulators fined foreign manufacturers of infant milk formula $110 million on allegations of price-fixing, the National Development and Reform Commission is reportedly threatening to issue stricter fines in the future. Six companies, including Mead Johnson, were hit with the fines after a four-month probe. China announced the fines on Wednesday. Just one day later, the NDRC said such practices will earn stricter fines: “If we discover firms knowingly breaking the law,” said NDRC head Xu Kunlin, “then fines will be increasingly severe. National media reported the milk formula fines set a record for China; all six companies said they would not contest the fines. The NDRC is currently probing the nation’s pharmaceutical industry, eying 60 companies, both foreign and domestic.
Featured News
France Competition Watchdog Dismisses Qwant Complaint Against Microsoft
Dec 21, 2025 by
CPI
US Regulators Clear Nvidia–Intel Technology Tie-Up
Dec 21, 2025 by
CPI
European Union Reaches Landmark Agreement on Digital Euro Framework
Dec 21, 2025 by
CPI
Trump Announces New Drug Pricing Deals With Major Pharmaceutical Companies
Dec 21, 2025 by
CPI
Coinbase Sues Three States Over Prediction Market Regulations
Dec 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi